Wall Street research analysts offer views on future stock movement of Bristol-Myers Squibb Company (NYSE:BMY). These opinions are based on extensive research and broad knowledge of the company. Analysts polled by Thomson Reuters have set a consensus target price of $62.5100 on shares. Target prices may vary from one analyst to another due to the various ways they may proceed to calculate future price targets.
After a recent check on the stock, shares have been seen trading $2.8873 away from the 50-day moving average of $52.7163 and $-7.2692 away from the 200-day moving average of $62.8728. The stock has been recently noted at -27.8999% off of the 52-week high of 77.1200 and +13.4073% separated from the 52-week low of 49.0300. Monitoring the stock price relative to moving averages as well as 52 week highs and lows may help with the evaluation of future stock performance.
Analysts that track the company may use various metrics to aid with calculating target price predictions.
A frequently used metric is a company’s price to earnings ratio. This calculation is derived by dividing the current share price by the projected earnings per share. Bristol-Myers Squibb Company Co currently has a P/E Ratio of 27.8157. Traders may also keep an eye on a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the expected future growth rate of the company. A PEG Ratio below one may represent that the company is undervalued. If the company’s PEG Ratio is higher than one, it may indicate that the company is overvalued. A PEG Ratio near one may be viewed as fair value. The company has a current PEG Ratio of 1.1100.